•Dengue virus serotype 4-leading serotype epidemic and its clinical and molecular characteristics in Vung Tau, South Vietnam, 2020-2021
•Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease
•Optimizing Approach to Liver Biochemistry Abnormalities in Cystic Fibrosis Pediatrics: Balancing Efficiency and Risk-Benefit
•External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver Disease
•When Infection Masquerades as Metastasis: Tuberculous Spondylodiscitis with Fibrous Dysplasia and Capillary Hemangioma in a Patient with Newly Diagnosed Hepatic Mass
